U.S. flag An official website of the United States government.
Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Morbidity and Mortality Weekly Report (MMWR)

CDC Stacks Public Health Publications

The Morbidity and Mortality Weekly Report (MMWR) series are CDC’s primary vehicle for scientific publication of timely, reliable, authoritative, accurate, objective, and useful public health information and recommendations. The MMWR series includes the following publications: MMWR Weekly, MMWR Recommendations and Reports, CDC Surveillance Summaries and MMWR Supplements. These journals are freely available to the public as Diamond Open Access. For more on MMWR, visit https://www.cdc.gov/mmwr/index.html.

(45)
(67)
(184)
(229)
(500)
(673)
(659)
(403)
(489)
(557)
(246)
(325)
(427)
(406)
(97)
(156)
(103)
(110)
(97)
(92)
(119)
(92)
(108)
(96)
(97)
(92)
(79)
(97)
(87)
(91)
(88)
(76)
(74)
(84)
(80)
(69)
(70)
(73)
(68)
(69)
(59)
(67)
(62)
(64)
(62)
(66)
(72)
(55)
(53)
(55)
(60)
(56)
(58)
(54)
(53)
(56)
(55)
(52)
(54)
(53)
(54)
(54)
(53)
(53)
(53)
(53)
(54)
(53)
(53)
(53)
(53)
(54)
(53)
(53)
(51)
0 of 75
(44)
(63)
(187)
(222)
(500)
(663)
(656)
(409)
(483)
(558)
(231)
(311)
(436)
(413)
(91)
(148)
(100)
(104)
(102)
(92)
(120)
(92)
(104)
(97)
(97)
(91)
(80)
(97)
(86)
(90)
(87)
(76)
(75)
(84)
(80)
(69)
(69)
(71)
(69)
(64)
(60)
(68)
(62)
(62)
(62)
(67)
(72)
(56)
(55)
(54)
(59)
(57)
(58)
(54)
(53)
(55)
(55)
(55)
(53)
(53)
(53)
(53)
(54)
(53)
(53)
(53)
(53)
(53)
(54)
(54)
(53)
(53)
(53)
(53)
(54)
0 of 75
(1)
(7)
(33)
(71)
(44)
(137)
(157)
(161)
(151)
(137)
(163)
(169)
(155)
(160)
(161)
(157)
(163)
(164)
(156)
(164)
(156)
(173)
(142)
(155)
(159)
(134)
(156)
(141)
(142)
(141)
(137)
(138)
(142)
(131)
(162)
(144)
(136)
(152)
(152)
(177)
(206)
(197)
(164)
(187)
(179)
(201)
(205)
(202)
(223)
(225)
(232)
(221)
(225)
(252)
(252)
(277)
0 of 56
(2)
(1)
(4)
(1)
(431)
(107)
(405)
(13)
(8547)
0 of 9
(16)
(34)
(37)
(4)
(1)
(2)
(6)
(1)
0 of 8
(10)
(10)
(25)
(11)
(7)
(20)
(27)
(42)
(58)
(7)
(23)
(13)
(7)
(38)
(10)
(10)
(50)
(7)
(33)
(1236)
(23)
(1293)
(32)
(71)
(10)
(91)
(26)
(16)
(7)
(791)
(198)
(24)
(128)
(70)
(39)
(61)
(10)
(9)
(11)
(17)
(20)
(38)
(19)
(26)
(15)
(26)
(9)
(11)
(17)
(10)
(7)
(48)
(11)
(8)
(223)
(17)
(17)
(8)
(181)
(137)
(129)
(32)
(8)
(15)
(13)
(9)
(10)
(13)
(15)
(9)
(15)
(8)
(29)
(17)
(10)
(7)
(18)
(100)
(13)
(12)
(36)
(18)
(8)
(12)
(7)
(11)
(11)
(30)
(9)
(9)
(9)
(15)
(21)
(8)
(17)
(7)
(8)
(31)
(77)
(10)
(61)
(7)
(7)
(14)
(12)
(13)
(15)
(19)
(85)
(13)
(11)
(14)
(31)
(14)
(13)
(30)
(28)
(12)
(187)
(7)
(7)
(17)
(8)
(18)
(53)
(11)
(7)
(17)
(22)
(20)
(7)
(15)
(10)
(9)
(24)
(13)
(31)
(20)
(29)
(7)
(13)
(13)
(31)
(73)
(10)
(21)
(24)
(8)
(26)
(20)
(7)
(7)
(8)
(13)
(28)
(25)
(9)
(940)
(740)
(9)
(14)
(7)
(14)
(35)
(7)
(103)
(10)
(51)
(10)
(19)
(11)
(11)
(9)
(58)
(12)
(20)
(14)
(49)
(20)
(21)
(19)
(20)
(16)
(177)
(80)
(2979)
(37)
(12)
(546)
(316)
(260)
(215)
(24)
(38)
(14)
(15)
(14)
(12)
(34)
(10)
(80)
(14)
(11)
(8)
(23)
(8)
(8)
(28)
(446)
(21)
(23)
(15)
(8)
(74)
(25)
(19)
(9)
(18)
(18)
(18)
(45)
(687)
(8)
(10)
(15)
(59)
(205)
(7)
(10)
(18)
(8)
(12)
(66)
(24)
(14)
(40)
(73)
(8)
(11)
(8)
(11)
(20)
(19)
(23)
(58)
(9)
(8)
(16)
(33)
(44)
(82)
(9)
(10)
(8)
(21)
(65)
(8)
(13)
(14)
(28)
(25)
(14)
(10)
(10)
(8)
(166)
(24)
(14)
(35)
(26)
(9)
(11)
(9)
(24)
(26)
(12)
(92)
(4170)
(636)
(34)
(12)
(17)
(10)
(14)
(11)
(12)
(13)
(9)
(28)
(16)
(19)
(8)
(8)
(12)
(27)
(17)
(14)
(44)
(20)
(28)
(36)
(10)
(20)
(8)
(21)
(8)
(66)
(91)
(24)
(9)
(27)
(13)
(21)
(22)
(8)
(39)
(56)
(68)
(21)
(15)
(149)
(8)
(12)
(32)
(16)
(14)
(19)
(19)
(16)
(22)
(10)
(11)
(144)
(45)
(32)
(9)
(41)
(32)
(15)
(654)
(51)
(26)
(9)
(56)
(14)
(130)
(9)
(18)
(62)
(8)
(10)
(10)
(30)
(11)
(10)
(13)
(21)
(8)
(15)
(23)
(111)
(23)
(1338)
(14)
(10)
(17)
(11)
(13)
(8)
(8)
(48)
(8)
(25)
(186)
(14)
(42)
(45)
(25)
(47)
(13)
(16)
(11)
(593)
(394)
(15)
(21)
(14)
(152)
(15)
(53)
(9)
(28)
(10)
(19)
(11)
(8)
(8)
(110)
(10)
(78)
(11)
(52)
(68)
(59)
(17)
(23)
(60)
(132)
(19)
(105)
(58)
(12)
(39)
(126)
(35)
(97)
(17)
(10)
(11)
(12)
(12)
(8)
(14)
(52)
(69)
(116)
(29)
(172)
(25)
(17)
(50)
(12)
(10)
(33)
(12)
(10)
(45)
(11)
(8)
(8)
(60)
(31)
(90)
(44)
(19)
(159)
(10)
(14)
(31)
(8)
(8)
(9)
(9)
(12)
(28)
(51)
(9)
(206)
(18)
(31)
(17)
(19)
(2445)
(16)
(18)
(18)
(11)
(104)
(20)
(38)
(8)
(206)
(231)
(23)
(8)
(8)
(9)
(18)
(240)
(11)
(49)
(678)
(10)
(307)
(15)
(47)
(61)
(23)
(17)
(8)
(21)
(595)
(13)
(61)
(15)
(14)
(9)
(37)
(26)
(22)
(29)
(188)
(45)
(54)
(48)
(8)
(114)
(50)
(10)
(125)
(28)
(11)
(12)
(8)
(32)
(22)
(8)
(12)
(8)
(22)
(13)
(61)
(16)
(11)
(10)
(73)
(9)
(10)
(10)
(74)
(32)
(114)
(9)
(13)
(41)
(17)
(55)
(17)
(13)
(16)
(18)
(10)
(17)
(44)
(66)
(10)
(11)
(9)
(10)
(177)
(17)
(12)
(14)
(1181)
(9)
(9)
(8)
(50)
(10)
(44)
(109)
(10)
(16)
(8)
(19)
(308)
(40)
(33)
(23)
(11)
(12)
(9)
(83)
(11)
(12)
(18)
(20)
(8)
(11)
(8)
(8)
(19)
(58)
(32)
(82)
(14)
(37)
(8)
(21)
(40)
(13)
(17)
(17)
(9)
(9)
(66)
(19)
(963)
(103)
(15)
(48)
(30)
(12)
(8)
(10)
(57)
(3831)
(11)
(9)
(9)
(31)
(16)
(21)
(16)
(16)
(15)
(17)
(10)
(13)
(8)
(8)
(11)
(18)
(9)
(14)
(15)
(9)
(16)
(41)
(43)
(20)
(10)
(27)
(11)
(12)
(10)
(15)
(243)
(18)
(22)
(8)
(36)
(14)
(113)
(10)
(257)
(611)
(72)
(11)
(21)
(17)
(8)
(11)
(15)
(9)
(10)
(299)
(12)
(10)
(8)
(14)
(11)
(12)
(11)
(20)
(10)
(10)
(16)
(13)
(13)
(10)
(22)
(10)
(65)
(10)
(9)
(10)
(9)
(9)
(19)
(12)
(9)
(144)
(18)
(14)
(8)
(33)
(144)
(11)
(171)
(10)
(8)
(8)
(22)
(70)
(343)
(114)
(84)
(24)
(36)
(34)
(11)
(30)
(14)
(8)
(10)
(25)
(21)
(29)
(21)
(18)
(16)
(1141)
(18)
(27)
(18)
(22)
(110)
(15)
(22)
(23)
(349)
(10)
(18)
(72)
(16)
(15)
(26)
(14)
(27)
(35)
(10)
(9)
(11)
(216)
(50)
(16)
(23)
(34)
(21)
(10)
(19)
(74)
(20)
(9)
(233)
(1003)
(22)
(24)
(71)
(101)
(2518)
(11)
(104)
(12)
(23)
(15)
(16)
(14)
(93)
(177)
(38)
(279)
(15)
(8)
(9)
(13)
(45)
(32)
(91)
(9)
(17)
(18)
(16)
(23)
(71)
(37)
(18)
(12)
(8)
(12)
(21)
(10)
(28)
(10)
(10)
(8)
(24)
(104)
(187)
(28)
(29)
(25)
(10)
(20)
(9)
(58)
(67)
(195)
(303)
(8)
(14)
(11)
(21)
(12)
(8)
(58)
(17)
(34)
(9)
(38)
(617)
(31)
(32)
(146)
(241)
(12)
(177)
(10)
(18)
(10)
(122)
(8)
(11)
(126)
(9)
(16)
(18)
(15)
(20)
(11)
(9)
(19)
(11)
(28)
(35)
(38)
(11)
(8)
(65)
(22)
(16)
(40)
(28)
(10)
(14)
(10)
(14)
(12)
(80)
(31)
(8)
(39)
(9)
(20)
(18)
(12)
(184)
(9)
(28)
(23)
(70)
(25)
(23)
(25)
(14)
(8)
(9)
(108)
(8)
(22)
(16)
(44)
(16)
(134)
(51)
(10)
(19)
(10)
(56)
(9)
(8)
(12)
(18)
(94)
(35)
(31)
(12)
(49)
(8)
(38)
(91)
(9)
(22)
(14)
(182)
(10)
(8)
(8)
(19)
(33)
(21)
(19)
(12)
(8)
(69)
(9)
(8)
(54)
(15)
(12)
(8)
(15)
(8)
(10)
(58)
(19)
(181)
(28)
(36)
(22)
(106)
(19)
(157)
(13)
(9)
(12)
(15)
(68)
(9)
(14)
(182)
(10)
(10)
(19)
(70)
(18)
(29)
(17)
(50)
(17)
(19)
(9)
(14)
(464)
(11)
(48)
(49)
(104)
(17)
(102)
(29)
(25)
(34)
(21)
(40)
(8)
(10)
(23)
(31)
(20)
(35)
(21)
(12)
(18)
(8)
(43)
(94)
(22)
(26)
(9)
(23)
(9)
(12)
(8)
(39)
(14)
(14)
(59)
(11)
(9)
(38)
(17)
(16)
(39)
(15)
(78)
(8)
(10)
(43)
(13)
(15)
(46)
(27)
(763)
(30)
(57)
(10)
(12)
(29)
0 of 1000
(12)
(12)
(15)
(7)
(23)
(9)
(7)
(18)
(8)
(7)
(10)
(11)
(7)
(9)
(7)
(10)
(9)
(11)
(11)
(19)
(9)
(11)
(9)
(10)
(27)
(8)
(9)
(12)
(23)
(15)
(9)
(7)
(7)
(7)
(9)
(13)
(11)
(9)
(15)
(7)
(7)
(7)
(7)
(9)
(8)
(19)
(9)
(9)
(7)
(7)
(13)
(7)
(7)
(9)
(7)
(9)
(7)
(16)
(13)
(7)
(12)
(12)
(22)
(28)
(15)
(8)
(8)
(13)
(7)
(19)
(12)
(12)
(13)
(15)
(16)
(9)
(10)
(7)
(11)
(28)
(7)
(13)
(28)
(7)
(10)
(11)
(11)
(13)
(10)
(8)
(18)
(9)
(10)
(16)
(29)
(8)
(12)
(12)
(13)
(8)
(9)
(7)
(28)
(9)
(16)
(7)
(29)
(7)
(8)
(8)
(11)
(16)
(16)
(12)
(35)
(8)
(11)
(16)
(18)
(9)
(29)
(9)
(14)
(22)
(31)
(11)
(7)
(7)
(10)
(7)
(18)
(9)
(7)
(9)
(7)
(7)
(7)
(11)
(9)
(23)
(20)
(10)
(7)
(7)
(15)
(10)
(8)
(37)
(8)
(22)
(10)
(16)
(11)
(10)
(24)
(13)
(7)
(11)
(7)
(9)
(11)
(9)
(12)
(21)
(9)
(9)
(7)
(11)
(7)
(16)
(9)
(7)
(9)
(12)
(19)
(12)
(7)
(7)
(7)
(11)
(10)
(7)
(9)
(24)
(7)
(8)
(10)
(12)
(8)
(13)
(25)
(23)
(7)
(24)
(16)
(9)
(7)
(10)
(9)
(8)
(8)
(13)
(9)
(9)
(10)
(7)
(10)
(7)
(20)
(8)
(9)
(7)
(18)
(17)
(11)
(10)
(12)
(9)
(12)
(7)
(9)
(7)
(9)
(8)
(15)
(8)
(8)
(13)
(28)
(7)
(18)
(8)
(12)
(15)
(7)
(7)
(17)
(17)
(8)
(16)
(8)
(20)
(7)
(8)
(11)
(11)
(21)
(8)
(11)
(10)
(13)
(9)
(8)
(7)
(12)
(8)
(15)
(9)
(11)
(7)
(17)
(12)
(17)
(16)
(7)
(18)
(24)
(11)
(7)
(7)
(12)
(8)
(19)
(20)
(16)
(11)
(12)
(7)
(8)
(10)
(14)
(16)
(7)
(9)
(11)
(20)
(15)
(9)
(16)
(48)
(9)
(11)
(24)
(11)
(8)
(9)
(7)
(10)
(9)
(7)
(10)
(8)
(53)
(13)
(9)
(11)
(15)
(42)
(16)
(8)
(8)
(29)
(10)
(7)
(10)
(8)
(8)
(24)
(8)
(11)
(12)
(8)
(13)
(21)
(24)
(10)
(10)
(16)
(20)
(11)
(10)
(15)
(17)
(12)
(18)
(7)
(17)
(16)
(10)
(15)
(18)
(14)
(16)
(22)
(7)
(9)
(17)
(12)
(15)
(8)
(18)
(20)
(15)
(11)
(29)
(7)
(10)
(23)
(7)
(7)
(27)
(8)
(7)
(26)
(18)
(8)
(12)
(11)
(8)
(36)
(15)
(12)
(7)
(8)
(15)
(16)
(7)
(7)
(9)
(10)
(9)
(17)
(7)
(12)
(12)
(13)
(12)
(16)
(9)
(13)
(8)
(15)
(24)
(8)
(8)
(8)
(7)
(17)
(9)
(7)
(28)
(12)
(15)
(13)
(9)
(7)
(7)
(9)
(8)
(7)
(8)
(14)
(9)
(14)
(17)
(7)
(8)
(7)
(10)
(11)
(7)
(16)
(9)
(59)
(12)
(8)
(8)
(7)
(7)
(9)
(7)
(18)
(7)
(8)
(18)
(9)
(15)
(10)
(8)
(25)
(11)
(8)
(9)
(14)
(26)
(23)
(8)
(43)
(11)
(14)
(7)
(15)
(11)
(20)
(7)
(28)
(15)
(10)
(9)
(25)
(18)
(7)
(8)
(8)
(7)
(18)
(15)
(15)
(11)
(7)
(8)
(7)
(10)
(14)
(8)
(30)
(15)
(7)
(9)
(19)
(18)
(15)
(9)
(7)
(7)
(8)
(13)
(11)
(15)
(17)
(8)
(49)
(7)
(32)
(13)
(10)
(16)
(7)
(23)
(24)
(9)
(10)
(25)
(8)
(20)
(7)
(7)
(13)
(7)
(11)
(9)
(7)
(7)
(10)
(9)
(8)
(9)
(7)
(7)
(10)
(16)
(14)
(12)
(7)
(10)
(20)
(9)
(15)
(7)
(7)
(11)
(12)
(11)
(13)
(8)
(7)
(19)
(26)
(17)
(7)
(15)
(9)
(8)
(18)
(17)
(8)
(8)
(12)
(7)
(10)
(7)
(9)
(8)
(18)
(18)
(11)
(8)
(35)
(21)
(7)
(7)
(18)
(9)
(7)
(10)
(7)
(10)
(9)
(14)
(14)
(10)
(24)
(12)
(8)
(53)
(7)
(7)
(7)
(19)
(8)
(10)
(10)
(8)
(10)
(7)
(9)
(8)
(8)
(20)
(13)
(27)
(8)
(8)
(19)
(7)
(19)
(7)
(11)
(7)
(12)
(7)
(11)
(11)
(28)
(10)
(9)
(7)
(20)
(10)
(13)
(7)
(8)
(9)
(13)
(11)
(10)
(7)
(13)
(9)
(7)
(10)
(8)
(7)
(7)
(10)
(14)
(9)
(38)
(23)
(10)
(8)
(7)
(10)
(11)
(10)
(13)
(15)
(10)
(7)
(17)
(10)
(7)
(7)
(11)
(11)
(12)
(8)
(10)
(18)
(14)
(8)
(10)
(21)
(16)
(14)
(14)
(9)
(15)
(9)
(19)
(24)
(11)
(20)
(21)
(16)
(7)
(7)
(10)
(23)
(7)
(8)
(17)
(7)
(9)
(10)
(7)
(7)
(17)
(8)
(8)
(7)
(9)
(9)
(13)
(10)
(8)
(13)
(9)
(13)
(8)
(18)
(7)
(7)
(27)
(12)
(8)
(15)
(9)
(17)
(8)
(18)
(7)
(26)
(12)
(9)
(11)
(22)
(7)
(10)
(7)
(7)
(13)
(7)
(7)
(8)
(10)
(21)
(15)
(14)
(35)
(18)
(7)
(7)
(7)
(8)
(21)
(16)
(24)
(24)
(18)
(8)
(7)
(18)
(12)
(7)
(7)
(13)
(25)
(7)
(8)
(12)
(11)
(19)
(7)
(27)
(18)
(10)
(10)
(8)
(12)
(7)
(7)
(7)
(10)
(7)
(7)
(10)
(16)
(12)
(10)
(7)
(18)
(7)
(25)
(10)
(15)
(10)
(18)
(24)
(13)
(16)
(9)
(19)
(13)
(26)
(16)
(18)
(8)
(10)
(8)
(10)
(14)
(7)
(10)
(7)
(13)
(7)
(7)
(11)
(17)
(15)
(13)
(13)
(13)
(8)
(33)
(8)
(11)
(11)
(8)
(11)
(12)
(21)
(10)
(9)
(12)
(23)
(8)
(11)
(14)
(8)
(19)
(11)
(8)
(8)
(11)
(9)
(8)
(11)
(10)
(8)
(8)
(14)
(13)
(10)
(16)
(9)
(30)
(11)
(11)
(10)
(14)
(23)
(8)
(9)
(12)
(11)
(10)
(8)
(8)
(9)
(20)
(17)
(12)
(10)
(8)
(18)
(13)
(17)
(11)
(9)
(29)
(10)
(9)
(13)
(11)
(8)
(29)
(13)
(13)
(9)
(11)
(40)
(8)
(10)
(12)
(14)
(8)
(13)
(16)
(9)
(12)
(8)
(9)
(11)
(8)
(9)
(40)
(10)
(9)
(20)
(17)
(8)
(24)
(13)
(10)
(24)
(9)
(18)
(20)
(9)
(9)
(8)
(8)
(29)
(15)
(8)
(73)
(9)
(38)
(8)
(23)
(10)
(24)
(9)
(12)
(9)
(8)
(10)
(12)
(11)
(8)
(22)
(9)
(13)
(10)
(16)
(8)
(9)
(13)
(17)
(11)
(8)
(12)
(15)
(9)
(9)
(13)
(9)
(8)
(20)
(14)
(32)
(9)
(16)
(10)
(10)
(10)
(12)
(8)
(9)
(33)
(16)
(8)
(10)
(8)
(11)
(13)
(14)
(21)
(10)
(15)
(8)
(8)
(12)
(8)
(15)
(12)
(18)
(9)
(12)
(13)
(13)
(23)
(11)
(15)
(11)
(9)
(8)
(8)
(13)
(25)
(13)
(17)
(8)
(13)
(11)
(13)
(11)
(9)
(10)
(8)
(10)
(21)
(13)
(21)
(23)
(25)
(8)
(9)
(11)
(11)
(15)
(10)
(13)
(10)
(9)
(19)
(14)
(10)
0 of 1000
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(6)
(1)
(5)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(5)
(4)
(1)
(1)
(1)
(1)
(3)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(3)
(1)
(2)
(1)
(1)
(1)
(1)
(7)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(9)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(3)
(1)
(3)
(1)
(2)
(1)
(2)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(7)
(3)
(2)
(3)
(1)
(1)
(1)
(1)
(9)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(9)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(8)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(13)
(1)
(1)
(7)
(1)
(16)
(14)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(2)
(1)
(33)
(1)
(2)
(106)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(4)
(1)
(3)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(6)
(1)
(2)
(1)
(1)
(1)
(1)
(4)
(1)
(3)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(3)
(1)
(1)
(2)
(68)
(1)
(4)
(1)
(1)
(1)
(1)
(2)
(2)
(4)
(1)
(1)
(1)
(8)
(4)
(1)
(3)
(6)
(5)
(2)
(1)
(11)
(1)
(2)
(3)
(1)
(7)
(1)
(4)
(1)
(1)
(1)
(3)
(1)
(6)
(1)
(1)
(1)
(1)
(8)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(12)
(1)
(3)
(1)
(1)
(3)
(1)
(1)
(116)
(1)
(2)
(1)
(1)
(4)
(22)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(3941)
(6)
(1)
(1)
(2)
(11)
(10)
(1)
(1)
(41)
(1)
(2)
(1)
(1)
(1)
(1)
(3)
(14)
(1)
(1)
(1)
(4)
(20)
(1)
(7)
(3)
(1)
(1)
(1)
(3)
(1)
(1)
(5)
(1)
(1)
(2)
(5)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(3)
(13)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(2)
(1)
(1)
(1)
(7)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(65)
(3)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(3)
(1)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(3)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(10)
(1)
(1)
(1)
(1)
(7)
(1)
(1)
(1)
(33)
(1)
(1)
(1)
(1)
(2)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(21)
(1)
(1)
(1)
(3)
(1)
(2)
(1)
(3)
(3)
(1)
(1)
(1)
(1)
(425)
(1)
(1)
(5)
(1)
(2)
(1)
(1)
(1)
(3)
(1)
(1)
(6)
(1)
(6)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(13)
(5)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(2)
(2)
(3)
(2)
(2)
(2)
(4)
(3)
(3)
(4)
(2)
(5)
(1)
(2)
(3)
(2)
(3)
(9)
(2)
(2)
(2)
(2)
(9)
(2)
(7)
(4)
(2)
(2)
(5)
(2)
(12)
(12)
(2)
(7)
(4)
(2)
(3)
(2)
(3)
(4)
(4)
(2)
(5)
(7)
(4)
(2)
(5)
(7)
(2)
(9)
(2)
(2)
(8)
(2)
(2)
(2)
(4)
(9)
(3)
(3)
(2)
(2)
(5)
(9)
(4)
(4)
(2)
(2)
(5)
(4)
(2)
(3)
(3)
(9)
(4)
(4)
(6)
(4)
(2)
(3)
(2)
(6)
(2)
(11)
(2)
(3)
(2)
(2)
(2)
(3)
(10)
(4)
(2)
(8)
(2)
(15)
(2)
(2)
(20)
(2)
(3)
(6)
(2)
(2)
(5)
(2)
(13)
(11)
(2)
(24)
(2)
(3)
(3)
(7)
(2)
(3)
(3)
(3)
(2)
(9)
(2)
(14)
(2)
(7)
(3)
(4)
(3)
(2)
(3)
(9)
(5)
(9)
(50)
(8)
(3)
(13)
(3)
(3)
(2)
(4)
(3)
(9)
(5)
(3)
(2)
(2)
(2)
(15)
(9)
(5)
(4)
(2)
(5)
(4)
(5)
(4)
(5)
(5)
(11)
(4)
(12)
(5)
(2)
(2)
(7)
(5)
(3)
(2)
(5)
(2)
(2)
(3)
(2)
(3)
(2)
(2)
(149)
(7)
(2)
(2)
(3)
(3)
(3)
(3)
(2)
(6)
(2)
(3)
(3)
(10)
(2)
(16)
(2)
(7)
(9)
(6)
(4)
(7)
(5)
(4)
(11)
(3)
(4)
(13)
(17)
(2)
(24)
(2)
(2)
(4)
(8)
(7)
(11)
(8)
(5)
(3)
(13)
(4)
(17)
(6)
(9)
(2)
(22)
(2)
(2)
(6)
(3)
(9)
(3)
(2)
(4)
(15)
(3)
(4)
(3)
(8)
(15)
(6)
(2)
(23)
(2)
(2)
(4)
(5)
(5)
(24)
(2)
(4)
(2)
(7)
(2)
(2)
(9)
(3)
(2)
(9)
(6)
(11)
(5)
(15)
(4)
(2)
(3)
(5)
(6)
(2)
(118)
(5)
(18)
(3)
(2)
(7)
(125)
(2)
(3)
(2)
(5)
(7)
(2)
(3)
(2)
(4)
(6)
(6)
(3)
(3)
(2)
(3)
(2)
(10)
(12)
(4)
(2)
(3)
(3)
(4)
(9)
(2)
(2)
(2)
(5)
(6)
(4)
(2)
(2)
(13)
(2)
(4)
(2)
(2)
(2)
(4)
(3)
(9)
(2)
(4)
(2)
(2)
(2)
(7)
(2)
(2)
(2)
(2)
(2)
(2)
(3)
(4)
(3)
(3)
(3)
(4)
(12)
(4)
(2)
(5)
(6)
(5)
(2)
(3)
(14)
(4)
(2)
(2)
(2)
(2)
(2)
(14)
(7)
(7)
(3)
(2)
(3)
(2)
(2)
(2)
(44)
(183)
(2)
(88)
(115)
(2)
(8)
(16)
(10)
(5)
(2)
(14)
(180)
(2)
(3)
(3)
(6)
(93)
(2)
(2)
(2)
(4)
(317)
(7)
(11)
(2)
(6)
(8)
(2)
(3)
(26)
(80)
(2)
(2)
(22)
(3)
(2)
(36)
(30)
(10)
(4)
(3)
(6)
(2)
(3)
(4)
(3)
(2)
(4)
(2)
(2)
(2)
(2)
(2)
(2)
(3)
(2)
(2)
(4)
(2)
(2)
(4)
(2)
(3)
(2)
(2)
(2)
(2)
(4)
(3)
(2)
(5)
(2)
(2)
(4)
(2)
(2)
(2)
(4)
(15)
(3)
(3)
(2)
(14)
(2)
(2)
(6)
(15)
(13)
(4)
(2)
(3)
(5)
(2)
(2)
(5)
(8)
(2)
(4)
(2)
(3)
(2)
(3)
(7)
(2)
(2)
(4)
(4)
(2)
(4)
(2)
(2)
(2)
(2)
0 of 1000
(2)
(1)
(113)
(2)
(8)
(1)
(2910)
(5)
(2018)
(13)
(35)
(84)
(3)
(1)
(1)
(2)
(4)
(14)
(1)
(53)
(4075)
(2)
(4)
0 of 23
(1)
(2)
(15)
(33)
(13)
(1)
(8)
(2)
(2)
(4)
(5)
(25)
(1)
(7)
(2)
(180)
(1)
(113)
(2)
(3)
(7)
(1)
(3)
(10)
(11)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(14)
(168)
(159)
(1)
(1)
(1)
(1)
(20)
(1)
(28)
(1)
(2)
(23)
(2)
(1)
(1)
(1)
(1)
(1)
(23)
(8)
(1)
(2)
(3)
(1)
(6)
(1)
(19)
(1)
(7)
(2)
(1)
(1)
(1)
(1)
(1)
(7)
(1)
(3)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(12)
(1)
(1)
(1)
(2)
(1)
(16)
(1)
(1)
(3)
(1)
(20)
(1)
(5)
(5)
(1)
(1)
(1)
(1)
(1)
(2)
(4)
(1)
(2)
(2)
(2)
(1)
(871)
(2)
(1)
(11)
(1)
(3)
(6)
(1)
(1)
(1)
(87)
(4)
(1)
(1)
(1)
(1)
(8)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(3)
(2)
(1)
(1)
(14)
(3)
(53)
(1)
(4)
(1)
(1)
(1)
(8)
(17)
(1)
(1)
(1)
(1)
(7)
(1)
(8)
(266)
(1)
(7)
(1)
(1)
(3)
(201)
(2)
(2)
(1)
(1)
(4)
(1)
(1)
(1)
(9)
(1)
(1)
(1)
(1)
(9)
(1)
(1)
(1)
(1)
(2)
(2)
(39)
(1)
(14)
(13)
(1)
(5)
(1)
(2)
(11)
(1)
(1)
(177)
(2)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(2)
(1)
(4)
(1)
(7)
(1)
(1)
(1)
(4)
(68)
(1)
(1)
(1)
(1)
(1)
(1)
(12)
(39)
(2)
(1)
(1)
(5)
(3)
(12)
(315)
(1)
(1)
(1)
(1)
(28)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(468)
(3)
(6)
(42)
(3)
(12)
(5)
(1)
(4)
(10)
(1)
(1)
(20)
(1)
(8)
(1)
(1)
(1)
(3)
(2)
(15)
(14)
(8)
(2)
(18)
(1)
(112)
(1)
(1)
(1)
(1)
(4)
(5)
(24)
(1)
(1)
(9)
(3)
(76)
(1)
(307)
(1)
(1)
(1)
(31)
(161)
(12)
(1)
(174)
(3)
(3)
(10)
(7)
(25)
(1)
(1)
(1)
(4)
(23)
(42)
(1)
(1)
(1)
(1)
(111)
(1)
(1)
(1)
(1)
(213)
(18)
(1)
(1)
(9)
(1)
(2)
(1)
(3)
(1)
(1)
(1)
(1)
(7)
(4)
(1)
(1)
(1)
(1)
(4)
(32)
(1)
(1)
(1)
(1)
(2)
(3)
(1)
(13)
(3)
(96)
(1)
(1)
(2)
(4)
(5)
(209)
(1)
(2)
(3)
(1)
(1)
(127)
(9)
(7)
(3)
(2)
(1)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(204)
(1)
(1)
(272)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(55)
(1)
(1)
(1)
(1)
(1)
(5)
(265)
(12)
(5)
(3)
(11)
(1)
(8)
(3)
(1)
(1)
(1)
(3)
(1)
(306)
(3)
(1)
(131)
(2)
(1)
(163)
(1)
(1)
(1)
(77)
(4)
(3)
(1)
(1)
(1)
(1)
(7)
(1)
(1)
(2)
(1)
(3)
(1)
(2)
(3)
(3)
(112)
(1)
(1)
(9)
(2)
(27)
(34)
(2)
(1)
(1)
(3)
(1)
(18)
(1)
(5)
(3)
(3)
(60)
(1)
(237)
(2)
(1)
(187)
(2)
(1)
(5)
(1)
(500)
(1)
(6)
(2)
(16)
(1)
(7)
(5)
(156)
(1)
(1)
(1)
(6)
(3)
(9)
(4)
(31)
(1)
(1)
(4)
(1)
(248)
(1)
(45)
(1)
(2)
(4)
(10)
(8)
(1)
(5)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(558)
(114)
(1)
(1)
(4)
(10)
(1)
(1)
(267)
(1)
(57)
(80)
(241)
(256)
(318)
(52)
(45)
(51)
(88)
(72)
(1)
(1)
(1)
(1)
(1)
(3)
(6)
(8)
(31)
(8)
(7)
(3)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(300)
(1)
(1)
(13)
(10)
(2)
(27)
(1)
(1)
(1)
(1)
(1)
(18)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(19)
(1)
(1)
(1)
(5)
(16)
(1)
(2)
(1)
(154)
(1)
(1)
(1)
(5)
(1)
(9)
(1)
(1)
(3)
(2)
(1)
(90)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(5)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(3)
(11)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(3)
(3)
(1)
(4)
(1)
(4)
(1)
(1)
(1)
(8)
(1)
(1)
(1)
(5)
(1)
(2)
(1)
(1)
(18)
(13)
(1)
(14)
(1)
(1)
(13)
(11)
(1)
(2)
(1)
(116)
(46)
(8)
(2)
(1)
(4)
(9)
(4)
(20)
(1)
(2)
(2)
(1)
(5)
(2)
(1)
(2)
(1)
(14)
(1)
(1)
(1)
(1)
(2)
(2)
(22)
(24)
(1)
(1)
(1)
(3)
(1)
(18)
(1)
(1)
(10)
(1)
(1)
(1)
(1)
(1)
(185)
(1)
(1)
(481)
(22)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(11)
(8)
(1)
(1)
(1)
(7)
(1)
(1)
(130)
(1)
(24)
(1)
(1)
(67)
(7022)
(1)
(11)
(1)
(1)
(5)
(11)
(154)
(1)
(1)
(11)
(79)
(1)
(1)
(3)
(31)
(3)
(1)
(4)
(215)
(4)
(2)
(1)
(1)
(30)
(2)
(1)
(390)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(256)
(1)
(1)
(195)
(1)
(1)
(2)
(1)
(45)
(1)
(3)
(9)
(6)
(8)
(9)
(1)
0 of 772
(1)
(55)
(9)
(2)
(2)
(25)
(294)
(2)
(2)
(2)
(3)
(1)
(5)
(27)
(1)
(3)
(5)
(14)
(61)
(10)
(1)
(2)
(5)
(1)
(729)
(2)
(2776)
(5)
(5)
(37)
(1)
(15)
(1)
(7)
(3)
(16)
(27)
(1)
(108)
(2)
(383)
(52)
(1)
(1)
(1)
(1)
(2027)
(1)
(5)
(1)
(8)
(366)
(4)
(3)
(50)
(3)
0 of 56
(3)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(2)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(9)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(8)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(3)
(1)
(2)
(3)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(6)
(5)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(3)
(1)
(1)
(2)
(2)
(1)
(1)
(2)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
0 of 794
(82)
(4)
(1)
(6)
0 of 4
Showing 1421 - 1440 of 9537 results
  • Prevalence of Inflammatory Bowel Disease Among Medicare FeeForService Beneficiaries United States 20012018
    Prevalence of Inflammatory Bowel Disease Among Medicare Fee-For-Service Beneficiaries — United States, 2001−2018
    Xu, Fang ;
    Carlson, Susan A.
    May 14 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Inflammatory bowel disease (IBD), including Crohn's disease and ulcerative Colitis, is characterized by chronic inflammation of the gastrointestinal tract. The number of affected persons Worldwide has increased from 3.7 million in 1990 to 6.8 million in 2017 (1). The disease is more prevalent among non-Hispanic White persons than it is among person ...
    Supporting Files Public Domain
  • Morbidity and Mortality Weekly Report MMWR Surveillance Summaries May 2021 Vol 70 No SS3
    Morbidity and Mortality Weekly Report (MMWR): Surveillance Summaries, May 2021 / Vol. 70 / No. SS-3
    Lu, Peng-Jun ;
    Hung, Mei-Chuan
    May 14, 2021 | Surveillance Summaries: Morbidity and Mortality Weekly Report (MMWR)
    Problem/ConditionAdults are at risk for illness, hospitalization, disability and, in some cases, death from vaccine-preventable Diseases, particularly influenza and pneumococcal disease. CDC recommends vaccinations for adults on the basis of age, health conditions, prior vaccinations, and other considerations. Updated vaccination Rec. from CDC are ...
    Supporting Files Public Domain
  • Surveillance of Vaccination Coverage Among Adult Populations US 2018 Figure Estimated Proportion of Adults Aged 19 Years Who Received Selected Vaccines by Age Group and Risk Status National Health Interview Survey United States 20102018
    Surveillance of Vaccination Coverage Among Adult Populations —U.S. 2018: Figure. Estimated Proportion of Adults Aged ≥19 Years Who Received Selected Vaccines, by Age Group and Risk Status — National Health Interview Survey, United States, 2010–2018
    National Center for Immunization and Respiratory Diseases (U.S.). Immunization Services Division
    05/14/2021 | Surveillance Summaries: Morbidity and Mortality Weekly Report (MMWR)
    Figure for: Lu P, Hung M, Srivastav A, et al. Surveillance of Vaccination Coverage Among Adult Populations — United States, 2018. MMWR Surveill Summ 2021;70(No. SS-3):1–26.
    Public Domain
  • Surveillance of Vaccination Coverage Among Adult Populations US 2018 Supplementary Box 2 Vaccination coverage among health care personnel HCP aged 19 years for selected vaccines National Health Interview Survey United States 2018
    Surveillance of Vaccination Coverage Among Adult Populations —U.S. 2018: Supplementary Box 2. Vaccination coverage among health care personnel (HCP) aged >19 years for selected vaccines — National Health Interview Survey, United States, 2018
    Centers for Disease Control and Prevention (U.S.)
    05/14/2021 | Surveillance Summaries: Morbidity and Mortality Weekly Report (MMWR)
    No Description
    Public Domain
  • Interim Estimates of Vaccine Effectiveness of PfizerBioNTech and Moderna Covid19 Vaccines Among Health Care Personnel 33 US Sites JanuaryMarch 2021
    Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna Covid-19 Vaccines Among Health Care Personnel — 33 U.S. Sites, January–March 2021
    Pilishvili, Tamara ;
    Fleming-Dutra, Katherine E.
    May 14, 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    What is already known about this topic? Health care personnel (HCP) are at high risk for COVID-19. The early distribution of two mRNA COVID-19 vaccines (Pfizer-BioNTech and Moderna) to HCP provided an opportunity to examine vaccine effectiveness in a real-world setting.What is added by this report? The first U.S. multisite test-negative design vacc ...
    Supporting Files Public Domain
  • Surveillance of Vaccination Coverage Among Adult Populations US 2018 Supplementary Box 4 Estimated Proportion of Adults Aged 1926 Years Who Received at Least One Dose of Human Papillomavirus HPV Vaccine by Age Group Sex and Raceethnicity National Health Interview Survey United States 2018
    Surveillance of Vaccination Coverage Among Adult Populations —U.S. 2018: Supplementary Box 4. Estimated Proportion of Adults Aged 19–26 Years Who Received at Least One Dose of Human Papillomavirus (HPV) Vaccine, by Age Group, Sex, and Race/ethnicity —National Health Interview Survey, United States, 2018
    National Center for Immunization and Respiratory Diseases (U.S.). Immunization Services Division
    05/14/2021 | Surveillance Summaries: Morbidity and Mortality Weekly Report (MMWR)
    Table for: Lu P, Hung M, Srivastav A, et al. Surveillance of Vaccination Coverage Among Adult Populations — United States, 2018. MMWR Surveill Summ 2021;70(No. SS-3):1–26.
    Supporting Files Public Domain
  • Surveillance of Vaccination Coverage Among Adult Populations US 2018 Supplementary Box 5 Differences in Vaccination Coverage Among Adults Aged 19 Years for Select Vaccines by Raceethnicity Increasedrisk Status Health Insurance Status Age Group Access to Care Characteristics Nativity Number of Years Living in the United States and Citizenship National Health Interview Survey United States 2018
    Surveillance of Vaccination Coverage Among Adult Populations —U.S. 2018: Supplementary Box 5. Differences in Vaccination Coverage Among Adults Aged ≥19 Years for Select Vaccines, by Race/ethnicity, Increased–risk Status, Health Insurance Status, Age Group, Access to Care Characteristics, Nativity, Number of Years Living in the United States, and Citizenship —National Health Interview Survey, United States, 2018
    National Center for Immunization and Respiratory Diseases (U.S.). Immunization Services Division
    05/14/2021 | Surveillance Summaries: Morbidity and Mortality Weekly Report (MMWR)
    Table for: Lu P, Hung M, Srivastav A, et al. Surveillance of Vaccination Coverage Among Adult Populations — United States, 2018. MMWR Surveill Summ 2021;70(No. SS-3):1–26.
    Supporting Files Public Domain
  • Surveillance of Vaccination Coverage Among Adult Populations US 2018 Supplementary Box 1 Selected Conditions That Increase the Risk for Complications of Influenza and Increase the Risk for Pneumococcal Disease for Which Survey Collects Data and Are Defined as Indications for Influenza or Pneumococcal Vaccines by the Advisory Committee on Immunization Practices
    Surveillance of Vaccination Coverage Among Adult Populations —U.S. 2018: Supplementary Box 1. Selected Conditions That Increase the Risk for Complications of Influenza and Increase the Risk for Pneumococcal Disease for Which Survey Collects Data and Are Defined as Indications for Influenza or Pneumococcal Vaccines by the Advisory Committee on Immunization Practices.
    National Center for Immunization and Respiratory Diseases (U.S.). Immunization Services Division
    05/14/2021 | Surveillance Summaries: Morbidity and Mortality Weekly Report (MMWR)
    Table for: Lu P, Hung M, Srivastav A, et al. Surveillance of Vaccination Coverage Among Adult Populations — United States, 2018. MMWR Surveill Summ 2021;70(No. SS-3):1–26.
    Public Domain
  • Demographic and Social Factors Associated with COVID19 Vaccination Initiation Among Adults Aged 65 Years United States December 14 2020April 10 2021
    Demographic and Social Factors Associated with COVID-19 Vaccination Initiation Among Adults Aged ≥65 Years — United States, December 14, 2020–April 10, 2021
    Abad, Neetu ;
    Barbour, Kamil E.
    2021/05/14 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Compared with other age groups, older adults (defined here as persons aged ≥65 years) are at higher risk for COVID-19-associated morbidity and Mortality and have therefore been prioritized for COVID-19 vaccination (1,2). Ensuring access to vaccines for older adults has been a focus of federal, state, and local response efforts, and CDC has been mon ...
    Supporting Files Public Domain
  • After Initially Decreasing in Early 2021 Adolescent Hospitalization Rates for COVID19 Increased During MarchApril
    After Initially Decreasing in Early 2021, Adolescent Hospitalization Rates for COVID-19 Increased During March-April
    Centers for Disease Control and Prevention (U.S.)
    May 14, 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Illustration accompanying: Havers FP, Whitaker M, Self JL, et al. "Hospitalization of adolescents aged 12–17 years with laboratory-confirmed COVID-19 — COVID-NET, 14 states, March 1, 2020–April 24, 2021" 70 (2021)
    Public Domain
  • The Advisory Committee on Immunization Practices Interim Recommendation for Use of PfizerBioNTech COVID19 Vaccine in Adolescents Aged 1215 Years United States May 2021
    The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12–15 Years — United States, May 2021
    Wallace, Megan ;
    Woodworth, Kate R.
    May 14, 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    What is already known about this topic? On May 10, 2021, the Food and Drug Administration expanded Emergency Use Authorization for the Pfizer-BioNTech COVID-19 vaccine to include adolescents aged 12–15 years.What is added by this report? On May 12, 2021, after a systematic review of all available data, the Advisory Committee on Immunization Practic ...
    Supporting Files Public Domain
  • Vaccine Effectiveness Update Realworld Data Show MRNA Vaccines Are Highly Effective at Preventing COVID19 Among Health Care Personnel
    Vaccine Effectiveness Update: Real-world Data Show MRNA Vaccines Are Highly Effective at Preventing COVID-19 Among Health Care Personnel
    Centers for Disease Control and Prevention (U.S.)
    May 14, 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Illustration accompanying: Tenforde MW, Olson SM, Self WH, et al. Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years — United States, January–March 2021. MMWR Morb Mortal Wkly Rep 2021;70:674–679.mm7020e2_EffectivenessPfizerModernaHCP_IMAGE_14May21_1200x675-medium.jpg
    Public Domain
  • MMWR Morbidity and Mortality Weekly Report Vol 70 No 19 May 14 2021
    MMWR. Morbidity and Mortality Weekly Report, Vol. 70, No. 19, May 14, 2021
    Centers for Disease Control and Prevention (U.S.)
    05/14/2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Emergency Department Visits for Bicycle-Related Traumatic Brain Injuries Among Children and Adults — United States, 2009–2018Prevalence of Inflammatory Bowel Disease Among Medicare Fee-For-Service Beneficiaries — United States, 2001−2018Diagnostic Performance of an Antigen Test with RT-PCR for the Detection of SARS-CoV-2 in a Hospital Setting — Los ...
    Public Domain
  • Emergency Department Visits for BicycleRelated Traumatic Brain Injuries Among Children and Adults United States 20092018
    Emergency Department Visits for Bicycle-Related Traumatic Brain Injuries Among Children and Adults — United States, 2009–2018
    Sarmiento, Kelly ;
    Haileyesus, Tadesse
    2021/05/14 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Bicycling leads to the highest number of sport and recreation-related emergency department (ED) visits for traumatic brain injuries (TBIs) in the United States (1). Because bicycling continues to grow in popularity,* primarily among U.S. adults, examining the strategies that mitigate the risk for TBI is important. CDC analyzed data from the Nationa ...
    Supporting Files Public Domain
  • QuickStats Percentage of Adults Aged 50 Years with Osteoporosis by Race and Hispanic Origin US 20172018
    QuickStats: Percentage of Adults Aged ≥50 Years with Osteoporosis, by Race and Hispanic Origin — U.S. 2017–2018
    Wambogo, Edwina ;
    Sarafrazi, Neda
    05/14/2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    During 2017–2018, the age-adjusted prevalence of osteoporosis among adults aged ≥50 years was 12.6%. A lower percentage of non-Hispanic Black adults (6.8%) had osteoporosis compared with non-Hispanic White adults (12.9%), non-Hispanic Asian adults (18.4%), and Hispanic adults (14.7%). The observed differences among non-Hispanic White, non-Hispanic ...
    Supporting Files Public Domain
  • Demographic and Social Factors Associated with COVID19 Vaccination Initiation Among Adults Aged 65 Years United States December 14 2020April 10 2021
    Demographic and Social Factors Associated with COVID-19 Vaccination Initiation Among Adults Aged ≥65 Years — United States, December 14, 2020–April 10, 2021
    Whiteman, Ari ;
    Wang, Alice
    May 11, 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    What is already known about this topic? Older adults have experienced higher risk for COVID-19–associated morbidity and Mortality and therefore have been prioritized for COVID-19 vaccination.What is added by this report? After the first 3.5 months of the U.S. COVID-19 vaccination program, 79.1% of adults aged ≥65 years had received ≥1 dose, with hi ...
    Supporting Files Public Domain
  • Vaccine United States MarchApril 2021
    Vaccine — United States, March–April 2021
    Shay, David K. ;
    Gee, Julianne
    5 07 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    On February 27, 2021, the Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for Janssen (Ad.26.COV2.S) COVID-19 vaccine (Janssen Biotech, Inc., a Janssen Pharmaceutical company, Johnson & Johnson) (1). The Janssen COVID-19 vaccine, the third COVID-19 vaccine authorized for use in the United States, uses a replication-in ...
    Supporting Files Public Domain
  • Emergency Department Visits and Hospitalizations for Selected Nonfatal Injuries Among Adults Aged 65 Years United States 2018
    Emergency Department Visits and Hospitalizations for Selected Nonfatal Injuries Among Adults Aged ≥65 Years — United States, 2018
    Moreland, Briana ;
    Lee, Robin
    5 07 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Approximately 60,000 older adults (aged ≥65 years) die from unintentional injuries each year; in 2019 these included 34,000 fall deaths, 8,000 traffic-related motor vehicle crash deaths, and 3,000 drug poisoning deaths (1). In addition, >9,000 suicide deaths occur among older adults each year (1). Deaths among older adults account for 33% of these ...
    Supporting Files Public Domain
  • Effectiveness of PfizerBioNTech and Moderna Vaccines Against COVID19 Among Hospitalized Adults Aged 65 Years United States JanuaryMarch 2021
    Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years — United States, January–March 2021
    Tenforde, Mark W. ;
    Olson, Samantha M.
    5 07 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Adults aged ≥65 years are at increased risk for severe outcomes from COVID-19 and were identified as a priority group to receive the first COVID-19 vaccines approved for use under an Emergency Use Authorization (EUA) in the United States (1-3). In an evaluation at 24 hospitals in 14 states,* the effectiveness of partial or full vaccination| with Pf ...
    Supporting Files Public Domain
  • AnxietyRelated Adverse Event Clusters After Janssen COVID19 Vaccination Five US Mass Vaccination Sites April 2021
    Anxiety-Related Adverse Event Clusters After Janssen COVID-19 Vaccination — Five U.S. Mass Vaccination Sites, April 2021
    Hause, Anne M. ;
    Gee, Julianne
    5 07 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    On April 7, 2021, after 5 weeks' use of the Janssen COVID-19 vaccine under the Food and Drug Administration (FDA) Emergency Use Authorization (EUA), CDC received reports of clusters of anxiety-related events after administration of Janssen COVID-19 vaccine from five mass vaccination sites, all in different states. To further investigate these cases ...
    Supporting Files Public Domain
1421 - 1440 / 9537
 Was this page helpful?
 Found an issue?
Send us an email at: publishinghd@cdc.gov